Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-19

Clinical Trial Update: A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating treatment patterns and outcomes in participants with HER2-positive unresectable locally …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer | Status: COMPLETED